Objective: Thioredoxin (TRX) is a redox regulatory protein that protects cells from various stresses. Angiotensin-converting enzyme (ACE) inhibitor was reported to enhance endogenous antioxidant enzyme activities. This study was carried out to investigate whether temocapril, a novel non-sulfhydryl-containing ACE inhibitor, reduces the severity of myocarditis via redox regulation mechanisms involving TRX. Methods and Results: In normal rat myocytes in vitro and in vivo, Western blot showed that temocapril enhanced cytosolic redox regulatory protein TRX expression, but that neither mitochondrial TRX2 nor antioxidant enzymes, such as copper-zinc superoxide dismutase (Cu / Zn-SOD) or manganese superoxide dismutase (Mn-SOD) expression, was up-regulated by the preconditioning treatment. In rats with experimental autoimmune myocarditis (EAM), the severity of myocarditis and the protein carbonyl contents were less increased in temocapril treatment (10 mg / kg / day, orally) from day 1 to day 21, but not in temocapril treatment from day 15 to day 21. An immunohistochemical study showed that TRX stain was enhanced in infiltrating inflammatory cells and in damaged myocytes. Considering the characteristics of this model that myocardial inflammation begins around day 15 and increases until day 21, temocapril treatment for 3 weeks might be thought of as a preconditioning treatment. Conclusions: The results suggest that TRX and the redox state modified by TRX may play a crucial role in the pathophysiology of EAM. Temocapril ameliorates myocarditis associated with inducing TRX up-regulation in a preconditioning manner, although the mechanism of TRX up-regulation by temocapril remains to be elucidated. up-regulated by acute inflammatory stimuli and may play were randomly separated into the temocapril-treated (n58) an important protective role in the pathogenesis and or temocapril-untreated (n58) groups. Temocapril-treated development of myocarditis [9] . rats were administered water containing 0.1 mg / ml Angiotensin-converting enzyme (ACE) inhibitors, fretemocapril (10 mg / kg / day) [17] and killed on day 8 quently used in the treatment of hypertension and cardiac (n54) or day 15 (n54). Temocapril-untreated rats were dysfunction, have been clarified to possess other pharmaadministered tap water alone and killed on day 8 (n54) or cological effects: they attenuate post-ischemic myocardial day 15 (n54). dysfunction [10] , inhibit complement-mediated myocardial injury [11] , and prevent endothelial dysfunction induced 2 .2.2. Immunization and treatment by oxidized low-density lipoprotein [12, 13] . It has been EAM was induced as previously described [9] . Porcine widely postulated that ROS are causally involved in these cardiac myosin (Sigma) was injected subcutaneously in the conditions. It was reported that ACE inhibitors enhanced foot pads with 0.1 ml of myosin (10 mg / ml) mixed with myocardial endogenous antioxidant enzyme activities such an equal volume of Freund's complete adjuvant (FCA) as copper, zinc superoxide dismutase (Cu / Zn-SOD) and supplemented with Mycobacterium tuberculosis H37Ra selenium-dependent glutathione peroxidase in normal mice (Difco) on days 1 and 8. Temocapril-treated rats (n510) [14] . Moreover, ACE inhibitors reduced myocardial inwere administered temocapril (10 mg / kg / day) from day 1 flammation and necrosis in murine viral myocarditis to day 21. Temocapril-untreated rats (n510) were adminis- [15, 16] . These findings prompted us to investigate whether tered tap water. In experiment II, temocapril-treated rats temocapril, a non-sulfhydryl containing ACE inhibitor, (n510) and temocapril-untreated rats (n59) were adminisreduces the severity of myocarditis by redox regulating tered temocapril or tap water separately from day 15 to day mechanisms. In this study, we investigate whether 21. Additional groups were control rats (without myosin temocapril treatment induces cardiomyocyte TRX expresinjection) treated from day 1 to day 21 in experiment I sion and if so, whether the enhanced TRX expression by (temocapril-treated, n54; temocapril-untreated, n54) and temocapril treatment has a beneficial effect on myocarditis.
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from day 15 to day 21 in experiment II (temocapril-treated, n54; temocapril-untreated, n54 At sacrifice, macroscopic findings were graded accorddispersed cells were incubated for 60 min at 37 8C.
ing to the following criteria: 0 (normal appearance), 1 (a Nonattached myocytes were collected and cultured in focal discolored area), 2 (multiple or diffuse discolored Dulbecco's modified Eagle's medium (DMEM; Nissui areas and not exceeding 1 / 3 of the heart), 3 (diffuse Pharmaceutical Co.) supplemented with 10% fetal calf discolored areas not exceeding 2 / 3 of the heart), and 4 serum (FCS), in a humidified atmosphere of 5% CO at (diffuse discolored areas exceeding 2 / 3 of the heart).
2 37 8C. Bromodeoxyurodine (BrdU, 100 mmol / l) was Pericardial effusion was graded: 0 (none), 1 (mild), and 2 added during the first 48 h to prevent proliferation of (massive). After macroscopic examination, the ventricles nonmyocytes. Spontaneously beating myocyte-rich culwere fixed in 10% formalin, transversely sliced, embedded 5 2 tures (final cell density, 10 cells / cm ) were then incuin paraffin, and stained with hematoxylin and eosin, to bated for 48 h without BrdU, followed by a final incubaexamine the degree of myocardial damage and infiltration tion in 10 ml fresh DMEM containing 10% FCS. During of inflammatory cells. Microscopic findings were graded: 0 this final incubation, myocytes were treated with temocap-(normal), 1 (lesion extent not exceeding 1% of a transverse ril (10 to 10 mol / l or absence) for 24 h. Cells were section), 2 (not exceeding 25%), 3 (not exceeding 50%), 4 lysed for assaying the TRX and SOD protein expressions.
(exceeding 50%). We measured the lesion area using a Temocapril was kindly provided by Sankyo Co. (Tokyo, square lattice scale in an eye lens of a microscope. Japan).
.4. Immunohistochemistry .2. Treatment protocol
To analyze the immunohistochemical stains of TRX and 2 .2.1. Preconditioning treatment TRX2, we used the immunoperoxidase technique [9] . To investigate the inductive effect of temocapril treatBriefly, deparaffinized slides were incubated with 3% ment on TRX and SOD expression in vivo, 6-to 7-week-H O for 10 min to inactivate the endogenous peroxidase 2 2 old Lewis rats (SHIMIZU Laboratory Supplies, Japan) activity. The primary antibodies (rabbit anti-mouse TRX, rabbit anti-mouse TRX2) or non-immune IgG were added 3 . Results and incubated overnight. The rabbit anti-mouse TRX and rabbit anti-mouse TRX2 antibodies cross-react on rat [9] .
3 .1. The effects of temocapril treatment on redox Biotinylated and affinity purified anti-rabbit IgG (Dako)
proteins TRX and TRX2, and antioxidant enzymes Cu / was used as a secondary antibody and incubated for 30
Zn-SOD and Mn-SOD in cultured cardiomyocytes in min. An avidin-biotin complex was sequentially added for vitro and in normal rats in vivo 5 min incubation with substrate 0.1% 39,39-diaminobenzidine, followed by hematoxylin nuclear counterstaining.
To examine the inductive effects of temocapril on redox proteins TRX and TRX2, and antioxidant enzymes Cu / Zn-SOD and Mn-SOD expressions in vitro, we treated cul-2 .5. Western blotting tured neonatal cardiomyocytes with temocapril for 24 h, followed by Western blotting as described in Section 2.1. The hearts were homogenized and lysed for 30 min.
As shown in Fig. 1 , temocapril treatment enhanced TRX Equal amounts of protein (10-20 mg protein / lane), estiprotein expression by 1.9-fold, but it had no effects on mated by the Bradford method (Bio-Rad), were elec-TRX2, Cu / Zn-SOD or Mn-SOD protein expression. trophoresed on a 15% sodium dodecyl sulfate-polyIn the in vivo study, normal rats were treated with acrylamide gel electrophoresis (SDS-PAGE), and sequentemocapril by preconditioning for 1 or 2 weeks as detially electrophoretically transferred to a polyvinylidene scribed in Section 2.2. The Western blotting showed that difluoride microporous membrane (Millipore). After blockthe expression of TRX on day 15, but not on day 8, was ing with 5% bovine serum albumin (BSA) in phosphateenhanced in temocapril-treated rats relative to that in the buffered saline (PBS) containing 0.05% Tween 20 at 4 8C temocapril-untreated group. TRX2, Cu / Zn-SOD and Mnovernight, the membrane was incubated with the primary SOD expression had not been significantly changed antibody, and then with a peroxidase-linked secondary throughout the entire period compared with the temocaprilantibody (Amersham). Chemiluminescence was detected untreated group (Fig. 2) . These findings showed that the with an ECL Western blot detection kit (Amersham) and induction of TRX expression by temocapril took at least semiquantitatively analyzed using an NIH Image system. longer than 15 days.
.2. Effects of temocapril on rats with EAM 2 .6. Detection of oxidized proteins in myocardium
EAM was induced in all the immunized rats. The Oxidative inactivation of enzymes and oxidative modisurvival in each group was 100% in this study. On day 22 fication of proteins by metal-catalyzed oxidation reactions at sacrifice, the hearts in rats without temocapril treatment are accompanied by the generation of protein carbonyl showed severe and diffuse discoloring (the arrow, Fig. 3A ) derivatives. Oxidized proteins were detected using an with massive pericardial effusion (the arrowhead, Fig. 3A ). oxidized protein detection kit (OxyBlot, Oncor) [18] . The Extensive injuries to myocytes with various kinds of OxyBlot provides reagents for sensitive immunodetection inflammatory changes, such as fragments of necrotic of carbonyl groups, which is a hallmark of the oxidation myocardial fibers, mononuclear cells, polymorphonuclear status of all proteins. The carbonyl groups in the protein neutrophils, eosinophils, and multinucleated giant cells side chains are derivatized to 2,4-dinitrophenylhydrazone (arrows, Fig. 3B ) were observed. To determine whether the (DNP-hydrazone). The DNP-derivatized protein samples up-regulation of TRX by temocapril preconditioning treatwere separated on a 12% SDS-PAGE followed by Western ment has a beneficial effect on subsequent myocarditis, we blotting. The filters were incubated with a primary antidesigned two experiments. In experiment I, temocapril body specific to the DNP moiety of the proteins, followed administration from day 1 to 21, myocarditis was ameliorby incubation with a peroxidase-linked secondary antiated to a certain extent: some hearts showed mild and focal body. The amount of protein carbonyl groups extracted discolor macroscopically and a few infiltrating inflammafrom 20 mg of sample proteins was measured using an tory cells microscopically (Fig. 3C , E, and F). The severity image analyzer and compared with 2.5 ml of the DNPof myocarditis in the temocapril-treated group was deprotein standard mixture (an internal control for OxyBlot).
creased moderately but significantly as assessed by measuring HW/ BW, macroscopic and microscopic scores 2 .7. Statistics (Table 1) . In experiment II, temocapril administration from day 15 to 21, the severity of myocarditis was not decreased All values were expressed as means6standard deviation significantly compared with those of temocapril-untreated (S.D.). One-way analysis of variance (ANOVA), following rats (Table 1 and Fig. 3G and H) . These results suggested by Fisher's protected least significant difference test, was that the up-regulation of TRX could protect rats from performed. A value of P,0.05 was considered statistically subsequent myocardial inflammation. significant.
No abnormalities were shown in cardiac pathology in control rats with / without temocapril-treatment in experi-TRX expression was up-regulated 2.7-fold in rats with ments I and II.
EAM compared with normal controls (Fig. 4) . But TRX2 expression was not significantly changed. It was suggested 3 .3. TRX and TRX2 expressions in rats with myocarditis that TRX but not TRX2 was induced by myocardial inflammation. Our previous study showed that TRX expression was
Immunohistochemistry was performed to determine the up-regulated in acute myocarditis and that the TRX histological localization of TRX and TRX2 in the hearts of expression corresponded well to the severity of myocar-EAM. TRX (Fig. 5A ) was strongly stained in both ditis [9] . In the present study, Western blotting showed that infiltrating inflammatory cells (arrows) in the necrotic areas and damaged myocytes (arrowheads) in the perinecrotic results, in addition to our previous study [9] , suggested that lesions. TRX2 (Fig. 5B ) stains were not enhanced in TRX but not TRX2 has a crucial role in the pathoinflammatory lesions or in damaged myocytes. These physiology of EAM. Myocarditis / temocapril(1), rats with autoimmune myocarditis treated with temocapril; myocarditis / temocapril(2), rats with autoimmune myocarditis untreated with temocapril; controls / temocapril(1), normal rats treated with temocapril; controls / temocapril(2), normal rats untreated with temocapril; HW/ BW, the ratio of heart weight and body weight. *P,0.05, **P,0.01 vs. myocarditis / temocapril(2).
It was suggested that cellular protein oxidative damage by increased ROS occurred in myocarditis. In rats with nonmyocarditis, the protein carbonyl contents were not significantly changed by the temocapril treatment (P5ns vs. controls). In rats with myocarditis, the protein carbonyl contents were decreased by the temocapril treatment in experiment I (P,0.01, Fig. 6 ) but not in experiment II (P5ns) compared with the untreated rats (data not shown), suggesting that temocapril prevented cellular proteins from oxidation in a preconditioning manner.
. Discussion
The present study provided evidence that temocapril treatment ameliorated EAM and prevented cellular proteins from oxidation in rats, associated with enhanced cardiomyocyte redox regulatory protein TRX expression.
The protein oxidation is an early intracellular indicator of tissue damage resulting from ROS. Oxidative inactivation of enzymes could lead to the disruption of cellular metabolism and seriously impair the ability of cells to repair this damage. In the present study, protein carbonyl content in myocarditis was increased, suggesting that each sample were loaded. In lanes 1 and 2, lysates were loaded from two TRX is a stress-inducible protein [19] . It has been different hearts of normal control rats; in lanes 3 and 4, lysates were from two hearts of rats with myocarditis. (B) Densitometric analysis of relative shown that TRX is involved in cellular protective mechaprotein levels. In rats with myocarditis, TRX expression was up-regulated nisms against various types of stress, such as ischemia / 2.7-fold; TRX2 expression was not significantly changed. Values were reperfusion, X-ray irradiation, hydrogen peroxide and derived from four animals, represented as the percentage of the control inflammatory cytokines [19] . Moreover, TRX is a value. *P,0.01 vs. controls.
scavenger of ROS, and recombinant human TRX has 3 .4. Changes in the oxidized proteins in myocardium protective activity against H O . Overexpression of TRX 2 2 in transgenic mice showed a protective activity against In rats with myocarditis, the protein carbonyl contents post-ischemic reperfusion injury in brain [20] . In the were markedly increased (P,0.01 vs. control rats, Fig. 6 ). present study, TRX expression was enhanced in infiltrating Twenty micrograms of protein of each sample were loaded. C, normal control rat; T, normal rat with temocapril treatment; M, rat with myocarditis without temocapril treatment; M1T, rat with myocarditis with temocapril treatment from day 1 to 21 in experiment I. All rats were killed on day 22. (B) Densitometric analysis of relative protein carbonyl contents. In rats with non-myocarditis, the protein carbonyl contents were not significantly changed by temocapril treatment. In rats with myocarditis, the protein carbonyl contents were markedly increased, and the increasing of protein carbonyl contents were suppressed by temocapril treatment in experiment I, but not in experiment II (data not shown) compared with the untreated rats. Values were derived from † four animals and represented as the percentage of the DNP-protein standards. *P,0.01 vs. normal controls; P,0.01 vs. rats with myocarditis without temocapril treatment.
inflammatory cells in the necrotic areas and in damaged tioning treatment. In addition, the protein carbonyl conmyocytes in perinecrotic lesions. Taken together, the uptents were less increased in experiment I, but not in regulated TRX may act as protection against ROS-meexperiment II, suggesting that temocapril may prevent diated myocardial injury. In the preconditioning expericellular proteins from oxidation by enhancing redox regment, it was shown that temocapril enhanced TRX protein ulatory protein TRX expression. Considering the characexpression in cultured myocytes and in normal hearts. In teristics of this model that myocardial inflammation begins rats with EAM, temocapril treatment for 3 weeks reduced around day 15 and increases until day 21, temocapril the severity of myocardial inflammation and necrosis in treatment for 3 weeks starting simultaneously with myosin experiment I where the improvement by the drug was immunization may be thought of as a preconditioning small but clear, but not in experiment II with no preconditreatment. Indeed, the induction of TRX by temocapril was
